Hanoi Oncology Hospital

What Hanoi Oncology Hospital does

Hanoi Oncology Hospital (Bệnh viện Ung Bướu Hà Nội) is a public, municipal tertiary-level oncology hospital in Hanoi, Vietnam, designated by the Ministry of Health as the final referral center (tuyến cuối) for cancer patients from all provinces. The hospital operates from its main campus at 42A Thanh Nhàn in Bạch Mai Ward, providing comprehensive cancer care spanning screening, diagnosis, surgery, chemotherapy, radiation therapy (including IMRT, VMAT, SBRT, SRS via Elekta Infinity linear accelerator), immunotherapy, targeted therapy, and palliative care. Diagnostic capabilities include mammography, 64-slice and 128-slice CT, 1.5 Tesla MRI, PET/CT, SPECT, molecular genetic sequencing, and immunohistochemistry, with interventional procedures such as Endoscopic Submucosal Dissection (ESD), radiofrequency ablation (RFA), and transarterial chemoembolization (TACE).

The hospital generates revenue from three principal streams: state budget allocations, Vietnam Social Health Insurance (BHYT) reimbursements — including cross-regional coverage for oncology — and fee-for-service premium on-demand consultations and treatment packages operating extended hours. A patient portal (phr.bvubhn.vn) supports appointment booking and result access. Distribution is entirely direct, via walk-in consultations, scheduled appointments, and a 24/7 emergency department, with no commercial marketing.

Strategic posture is defined by sustained international partnerships — most notably a renewed 2025-2027 AstraZeneca Vietnam MOU covering 28 active clinical trials and AI-assisted early diagnosis, alongside bilateral cooperation with Ajou University Hospital (Korea), Taipei Veterans General Hospital (Taiwan), TTY Biopharm, and ESMO patient-guide localization. Recent operational expansion includes a dedicated ICU launched in July 2026 and a co-led initiative with the Hanoi Department of Health to develop medical tourism as a new revenue channel. As a state-owned institution, the hospital has no private equity backing, no subsidiaries, and no public stock listing.

Name

Hanoi Oncology Hospital

Legal name

Bệnh viện Ung Bướu Hà Nội

Website

https://benhvienungbuouhanoi.vn

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Hanoi Oncology Hospital is a public tertiary-level oncology hospital in Hanoi designated by Vietnam's Ministry of Health as the final referral center for cancer patients nationwide, providing comprehensive screening, surgery, radiotherapy, chemotherapy, immunotherapy, and palliative care services.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Radiation Oncology (HLAKAFAC)

Keywords

• Oncology hospital services
• Cancer treatment services
• Radiation therapy services
• Cancer screening services
• Surgical oncology services

Headquarters

HQ city

Hanoi

HQ country

Vietnam

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Medical Examination and Treatment Services: As a public hospital, the hospital generates revenue through government-subsidized medical services, health insurance reimbursements (BHYT), and fee-for-service payments for premium on-demand examination and treatment services. The hospital publishes updated service fee tables annually.
2. Premium/On-Demand Healthcare Services: Revenue from specialized on-demand examination services, premium treatment packages, and additional medical services beyond the standard public healthcare offerings. These services operate extended hours and on Saturdays.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Hanoi Oncology Hospital is a public tertiary-level cancer hospital providing comprehensive oncology care from screening through palliative care. Its core offerings include on-demand examination and treatment services, multi-cancer-type screening packages, specialized technical services (advanced imaging, interventional procedures, major surgeries, radiotherapy, immunotherapy, targeted therapy, nuclear medicine), and remote multi-specialty consultation. The hospital is funded via state budgets, BHYT insurance reimbursements, and fee-for-service payments for premium on-demand care.

Product overview

Hanoi Oncology Hospital (Bệnh viện Ung Bướu Hà Nội) is a public, specialized tertiary-care oncology hospital in Hanoi, Vietnam, serving as the final referral center for cancer patients nationwide. The hospital operates a unified platform of cancer care services comprising four core offerings: (1) fee-based on-demand examination and treatment services (Dịch vụ Khám, chữa bệnh theo yêu cầu); (2) cancer screening packages for early detection across 10 cancer types (Dịch vụ Tầm soát phát hiện sớm ung thư), organized by gender and age; (3) specialized technical medical services (Dịch vụ Chuyên môn kĩ thuật đặc thù) covering diagnostic imaging (mammography, CT, MRI, PET/CT, SPECT), interventional procedures (ESD, RFA, TACE), major surgeries (hepatectomy, Whipple, microsurgery), and advanced radiotherapy (IMRT, VMAT, SBRT, Elekta Infinity); and (4) remote multi-specialty consultation (Dịch vụ Hội chẩn từ xa). Supporting these are sub-modules including the VABB breast biopsy technique, immunotherapy/targeted therapy, I-131 thyroid therapy, and a patient portal (PHR). International collaborations with AstraZeneca (AI-enabled early diagnosis), Ajou University Hospital (Korea), TTY Biopharm (Taiwan), and Bac Tai Veterans Hospital (Taiwan) complement the hospital's clinical portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

• On-demand Examination and Treatment Service (Dịch vụ Khám, chữa bệnh theo yêu cầu) Fee-based, on-demand examination and treatment service offering expedited consultations and medical care for patients seeking premium service outside the standard public pathway. Operates extended hours Monday through Saturday starting 6:00, with additional charges beyond standard BHYT-covered care.
• Cancer Screening and Early Detection Packages (Dịch vụ Tầm soát phát hiện sớm ung thư) Multi-cancer screening packages covering breast, thyroid, prostate, colorectal, gastric, liver, lung, head and neck, ovarian, and cervical cancers, organized by gender and age group to enable early cancer detection for asymptomatic and at-risk individuals.
• Specialized Technical Medical Services (Dịch vụ Chuyên môn kĩ thuật đặc thù) Comprehensive bundle of advanced diagnostic and treatment procedures including diagnostic imaging (mammography, 64/128-slice CT, 1.5T MRI, PET/CT, SPECT), interventional endoscopy (ESD), ablation (RFA, TACE), major surgeries (hepatectomy, Whipple, microsurgery, reconstructive surgery), immunotherapy and targeted therapy, advanced radiotherapy (IMRT, VMAT, SBRT, SRS using Elekta Infinity), and I-131 nuclear medicine therapy for cancer patients.
• Remote Multi-Specialty Consultation (Dịch vụ Hội chẩn khám chữa bệnh từ xa) Remote consultation and multi-specialty medical consultation service enabling patients and referring physicians to obtain expert oncology opinions and tumor board reviews without in-person visits.
• Patient Portal (Cổng thông tin bệnh nhân / PHR) Online patient health record portal providing appointment booking, medical result lookup, and patient information access for registered users of Hanoi Oncology Hospital.

Quantifiable outcome

• ICU survival cases: Patients with >90% mortality prognosis successfully recovered after 4-6 days of intensive care
• +3 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• AstraZeneca Vietnam (Công ty TNHH AstraZeneca Việt Nam)coreStrategic or Co-development Partner · 26 March 2025Partnership renewal signed March 2025 for 2025-2027 period. AstraZeneca has been supporting the hospital since 2020 with molecular biology testing, AI-assisted early diagnosis, multidisciplinary tumor boards, scientific seminars, and international conference participation. Currently sponsoring 28 clinical trials at the hospital. Supported nearly 200 lung cancer patients with medication through the 'For a Healthy Lung' program 2021-2023. Provided access to international oncology organizations and professional networks.
• ESMO (European Society for Medical Oncology)coreStrategic or Co-development Partner · 1 January 2024Partnership for translating and publishing ESMO patient guide materials on common cancers into Vietnamese. Materials cover 13 cancer types including breast, lung, cervical, gastric, colorectal, liver, pancreatic, esophageal, prostate, ovarian cancers, plus guides on cancer pain and immunotherapy side effects.
• Havana Party Committee (Thành uỷ La Habana, Cuba)minorOthers · 10 June 2023Visit by high-level delegation from Havana Party Committee in June 2023 to strengthen health cooperation, particularly in oncology. Discussion of potential training exchanges and healthcare development collaboration between Hanoi and Havana.
• TTY Biopharm (Đài Loan)coreStrategic or Co-development Partner · 19 May 2023Partnership signed May 2023 for enhancing clinical practice capabilities and scientific research for oncology staff. TTY Biopharm facilitated connections between Hanoi Oncology Hospital and Taipei Veterans General Hospital for clinical exchange and training. They have connected hospital staff with scholarship programs in Taiwan and international cancer conferences in Taiwan and Asia.
• Taipei Veterans General Hospital (Bệnh viện Đa khoa Cựu chiến binh Đài Bắc)coreStrategic or Co-development Partner · 21 July 2021Bilateral cooperation memorandum signed July 2021 for teaching, training, research, and clinical skills related to radiation oncology. Regular online scientific seminars every 3 months for clinical experience exchange in radiation therapy and palliative care. Hospital staff have opportunities for training and clinical exchange visits.
• Ajou University Hospital (Hàn Quốc)coreStrategic or Co-development Partner · 16 January 2020Cooperation agreement signed January 2020 for training and human resource quality improvement. Ajou University Hospital has partnerships with over 10 hospitals in Vietnam and has trained nearly 100 Vietnamese learners since 2019. Four staff members (3 doctors, 1 nurse) from Hanoi Oncology Hospital were scheduled for interview for training programs. Ajou University Hospital has been a leading center in Korea since 1994, recognized as Gyeonggi Province's cancer center and ranked top in cancer surgery.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Tata Memorial Hospital: India's leading public tertiary cancer center and national referral hospital; comparable as a government-designated specialty cancer hospital with research, training, and comprehensive oncology service lines in an emerging Asian market.
• Bumrungrad International Hospital: Thai-based private tertiary hospital with a strong Southeast Asian medical-tourism franchise including oncology services; comparable as a regional specialty-care provider capturing international patients.
• Singapore National Cancer Centre: National public specialty cancer center in Singapore offering comprehensive oncology care and clinical research; comparable to Hanoi Oncology Hospital as a national tertiary cancer center with research partnerships and advanced radiotherapy.

Emerging players

• FV Hospital: Vietnam-based private tertiary hospital in Ho Chi Minh City with established oncology and radiotherapy services; comparable as a domestic Vietnamese competitor for premium oncology and international patient demand.
• Mount Elizabeth Hospital (Singapore): Major Singapore private hospital with significant oncology and radiotherapy services; comparable as a regional specialty care provider competing for oncology patients and international referrals.

Direct peers

• Bệnh viện Ung Bướu TP. Hồ Chí Minh (Ho Chi Minh City Oncology Hospital): Southern Vietnam's counterpart public tertiary oncology hospital with a comparable comprehensive cancer service line, advanced radiotherapy and surgical programs, and national referral catchment.
• Bệnh viện K (Vietnam National Cancer Hospital): Vietnam's other national-level public oncology hospital, located in Hanoi. Directly comparable as the country's main public tertiary cancer centers receiving nationwide referrals and offering similar surgical, radiation and medical oncology services.

Broad incumbents

• Fortis Healthcare (Oncology): India-headquartered private hospital chain operating specialized oncology programs across South Asia; comparable as a multi-site private oncology provider with technology-driven cancer care.
• Apollo Hospitals (Cancer Institute): Large private hospital network in India with a dedicated oncology program including radiation, surgery and medical oncology; comparable as a broad oncology provider across Asia with advanced equipment and cross-border patient flow.
• MD Anderson Cancer Center: Globally leading U.S. public/affiliated oncology hospital with comprehensive cancer care and clinical research; comparable as a national/international specialty cancer center with strong research and training programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCZ5wI2hnWRqx6XO8A0Ues7w
• Facebookfacebook.com/bvubhn
• LinkedInlinkedin.com/company/hanoi-oncology-hospital

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hanoi Oncology Hospital